pyridine and alpha-synuclein

pyridine has been researched along with alpha-synuclein in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hirohata, M; Ono, K; Yamada, M1
Dardou, D; Durif, F; Fleurance, R; Gryshkova, V; Hafidi, A; Loiodice, S; McGhan, P; Nogueira da Costa, A1
Manglano-Artuñedo, Z; Outeiro, TF; Peña-Díaz, S; Pinheiro, F; Pujols, J; Santos, J; Vasili, E; Ventura, S1

Other Studies

3 other study(ies) available for pyridine and alpha-synuclein

ArticleYear
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
    Experimental neurology, 2007, Volume: 205, Issue:2

    Topics: alpha-Synuclein; Benzothiazoles; Humans; Kinetics; Lewy Body Disease; Microfibrils; Microscopy, Atomic Force; Microscopy, Electron; Mutation; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Fluorescence; Thiazoles

2007
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
    Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:10

    Topics: alpha-Synuclein; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; Nucleus Accumbens; Parkinson Disease; Pramipexole; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Up-Regulation

2017
The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
    The Journal of biological chemistry, 2022, Volume: 298, Issue:5

    Topics: alpha-Synuclein; Amyloid; Humans; Lewy Bodies; Neuroprotective Agents; Parkinson Disease; Polymerization; Protein Aggregation, Pathological; Pyridines; Synucleinopathies

2022